| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 18/07/2013 | 21h30 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 21h30 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 21h06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 21h04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 21h03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 21h02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 21h02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 20h58 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 20h57 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 20h56 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 20h55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 20h53 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 20h52 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 20h50 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 19h49 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 19h48 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 19h48 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 19h48 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 19h47 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 19h47 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 19h46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 17h39 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 16/07/2013 | 19h43 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 16/07/2013 | 18h00 | PR Newswire (US) | Omthera Stockholders Approve Acquisition by AstraZeneca | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 11/07/2013 | 15h13 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 10/07/2013 | 23h07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 09/07/2013 | 15h59 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 09/07/2013 | 15h59 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 09/07/2013 | 12h00 | PR Newswire (US) | Omthera Pharmaceuticals Announces NDA Submission for Epanova™ for the Treatment of Patients with Very High Triglycerides | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 27/06/2013 | 17h54 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |